CLINICAL_TRIALS
other
· 2026-02-24
Clinical Trial Update: Switch Maintenance in Pancreatic [Phase 1, Phase 2]
Summary
A Phase 1/2 trial in pancreatic cancer evaluating switch maintenance has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: James Cleary, MD, PhD | Conditions: Pancreatic Cancer, Adenocarcinoma of the Pancreas | Phase 1, Phase 2 | Status: SUSPENDED